Skip to content
← Full study record

NCT02991898 · OUTCOME

Number of Participants With Incidence of Bacterial, Viral and Fungal Infections

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies · Source last updated 2020-09-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
1 year

What was measured

Evaluated with descriptive statistics and plots or cumulative incidence curves if enough evaluable patients are available for time-to-event endpoints.

Groups in this outcome

Treg Infusion

The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treg Infusion3

Reported measurements

Source class 1

Bacterial

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treg Infusion1Not reportedNot reportedNot reportedNot reported

Viral

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treg Infusion2Not reportedNot reportedNot reportedNot reported

Fungal

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treg Infusion0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        1
      title
      Bacterial
    2. measurements
      1. group Id
        OG000
        value
        2
      title
      Viral
    3. measurements
      1. group Id
        OG000
        value
        0
      title
      Fungal
denoms
  1. counts
    1. group Id
      OG000
      value
      3
    units
    Participants
description
Evaluated with descriptive statistics and plots or cumulative incidence curves if enough evaluable patients are available for time-to-event endpoints.
groups
  1. description
    The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion
    id
    OG000
    title
    Treg Infusion
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
1 year
title
Number of Participants With Incidence of Bacterial, Viral and Fungal Infections
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice